相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tumor-Infiltrating PD-1+Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
Yusuke Kitagawa et al.
CLINICAL COLORECTAL CANCER (2022)
Tumor-associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance
Ioana Plesca et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2022)
Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre
Thomas Myles Ashhurst et al.
CYTOMETRY PART A (2022)
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer
Walid K. Chatila et al.
NATURE MEDICINE (2022)
Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer
Marit E. van der Sande et al.
ANNALS OF SURGERY (2021)
Comprehensive Phenotyping of Human Dendritic Cells and Monocytes
Florian Mair et al.
CYTOMETRY PART A (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses
Aisling B. Heeran et al.
CANCERS (2021)
Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Yuqin Yang et al.
FRONTIERS IN ONCOLOGY (2021)
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer
Gerardo Gatti et al.
BREAST CANCER RESEARCH (2021)
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy
Carine El Sissy et al.
CLINICAL CANCER RESEARCH (2020)
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal Cancer
Juan M. Sendoya et al.
CANCERS (2020)
Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy
Hiroshi Miyakita et al.
ONCOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies
Tao Wan et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
Fanny E. R. Vuik et al.
GUT (2019)
Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma
Jason B. Muhitch et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer
Felix Wagner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer
In Ja Park et al.
ONCOTARGET (2017)
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
Melanie J. McCoy et al.
ONCOTARGET (2017)
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
Fahima Dossa et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
Mahshid Jalilian et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
M. J. McCoy et al.
BRITISH JOURNAL OF CANCER (2015)
CD8+and FOXP3+Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer
Eiji Shinto et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival
Martha L. Slattery et al.
CARCINOGENESIS (2011)
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
Koji Yasuda et al.
RADIATION ONCOLOGY (2011)
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival
Dirk Nagorsen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells
ACP Diederichsen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)